Trials / Completed
CompletedNCT07012616
Supraclavicular Brachial Plexus Block as Opioid Sparing Technique in Pediatrics Undergoing Arteriovenous Fistula Creation
Supraclavicular Brachial Plexus Block as Opioid Sparing Technique in Pediatrics Undergoing Arteriovenous Fistula Creation: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the efficacy of supraclavicular brachial plexus block as an opioid-sparing technique in pediatric patients undergoing arteriovenous fistula creation.
Detailed description
The global incidence of end-stage renal failure (ESRF) is increasing. The preferred procedure for patients with ESRF undergoing maintenance Haemodialysis (HD) is the placement of an arteriovenous fistula (AVF). In patients with ESRF, brachial plexus block (BPB) is frequently employed to administer anesthesia for the establishment or modification of AVF. This technique offers pain relief, sympathetic blockade, ideal surgical conditions, and a sufficient duration of postoperative block, preventing arterial spasms and graft thrombosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Supraclavicular brachial plexus block | Patients will receive an ultrasound-guided supraclavicular brachial plexus block. |
Timeline
- Start date
- 2025-06-10
- Primary completion
- 2026-01-15
- Completion
- 2026-01-15
- First posted
- 2025-06-10
- Last updated
- 2026-01-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07012616. Inclusion in this directory is not an endorsement.